CVS Health Corp (CVS) : Baring Asset Management Ltd reduced its stake in CVS Health Corp by 0.35% during the most recent quarter end. The investment management company now holds a total of 129,051 shares of CVS Health Corp which is valued at $11,966,899 after selling 458 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Jul 25, 2016.CVS Health Corp makes up approximately 0.94% of Baring Asset Management Ltd’s portfolio.
Other Hedge Funds, Including , Rehmann Capital Advisory Group reduced its stake in CVS by selling 592 shares or 3.68% in the most recent quarter. The Hedge Fund company now holds 15,481 shares of CVS which is valued at $1,435,553. CVS Health Corp makes up approx 0.26% of Rehmann Capital Advisory Group’s portfolio.Bright Rock Capital Management boosted its stake in CVS in the latest quarter, The investment management firm added 9,000 additional shares and now holds a total of 72,267 shares of CVS Health Corp which is valued at $6,977,379. CVS Health Corp makes up approx 2.21% of Bright Rock Capital Management’s portfolio.Strategic Advisors boosted its stake in CVS in the latest quarter, The investment management firm added 876 additional shares and now holds a total of 13,627 shares of CVS Health Corp which is valued at $1,321,819. CVS Health Corp makes up approx 0.74% of Strategic Advisors’s portfolio.Ruane Cunniff Goldfarb Inc reduced its stake in CVS by selling 1,125 shares or 7.04% in the most recent quarter. The Hedge Fund company now holds 14,856 shares of CVS which is valued at $1,439,101. CVS Health Corp makes up approx 0.01% of Ruane Cunniff Goldfarb Inc’s portfolio.
CVS Health Corp closed down -0.67 points or -0.72% at $92.72 with 61,20,631 shares getting traded on Friday. Post opening the session at $93.45, the shares hit an intraday low of $92.36 and an intraday high of $93.55 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .Shares were Reiterated by Deutsche Bank on Jun 22, 2016 to “Hold” and Lowered the Price Target to $ 99 from a previous price target of $105 .CVS Health Corp was Downgraded by Morgan Stanley to ” Equal-Weight” on Jun 20, 2016.
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.